Načítá se...
Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis
The proteasome inhibitor, bortezomib, is ineffective against many solid tumors. Nutlin-3 is a potent antagonist of human homolog of murine double minute 2/p53 interaction exhibiting promising therapeutic anti-cancer activity. In this study, we show that treatment of various p53-defective bortezomib-...
Uloženo v:
| Vydáno v: | Exp Mol Med |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5579507/ https://ncbi.nlm.nih.gov/pubmed/28798402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2017.112 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|